Skip to main content
BIODYNE CO., LTD. logo

BIODYNE CO., LTD. — Investor Relations & Filings

Ticker · 314930 ISIN · KR7314930009 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2023-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 314930

About BIODYNE CO., LTD.

https://biodyne.co.za/

BIODYNE CO., LTD. is a developer and manufacturer of medical devices, reagents, and consumables specializing in cancer diagnosis solutions. The company's core offering is the PATHPLORER Liquid-Based Cytology (LBC) system, which includes fully automatic cell preparation instruments and associated diagnostic kits. A key differentiator is its patented 'Blowing Technology,' a unique method for cell preparation in LBC diagnostics, which the company pioneered. BIODYNE focuses on providing advanced solutions for cytopathology to improve the accuracy and efficiency of disease screening.

Recent filings

Filing Released Lang Actions
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Biodyne' (바이오다인) covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a mandatory disclosure for company insiders (directors/executives) to report changes in their personal shareholdings, which corresponds to the 'Director's Dealing' category.
2023-08-02 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Biodyne' (주식회사 바이오다인) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business operations, management discussions, and corporate governance details, which is characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, but the full report itself. Q1 2023
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the change in share ownership by a company director (Jo Woo-seok) of Biodyne. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it documents insider transactions and changes in holdings by company executives.
2023-05-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This falls directly under the definition of a Declaration of Voting Results (DVA), as it reports the official outcomes of shareholder votes at the AGM.
2023-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of an outside director for the company 'Biodyne'. This falls under the category of board management and changes in corporate governance structure.
2023-03-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.